Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10552 | 31292497 | Sci Rep | Development of liver surface nodularity quantification program and its clinical application in nonalcoholic fatty liver disease. | 2019 | Details |
| A10553 | 31292380 | Intern Med | High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10554 | 31292182 | BMJ Open | Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study. | 2019 | Details |
| A10555 | 31292134 | Diabetes | Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. | 2019 | Details |
| A10557 | 31291245 | PLoS One | Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. | 2019 | Details |
| A10558 | 31291052 | Diabetes Metab Res Rev | Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population. | 2019 | Details |
| A10559 | 31290769 | Eur J Gastroenterol Hepatol | Arterial stiffness is associated independently with liver stiffness in biopsy-proven nonalcoholic fatty liver disease: a transient elastography study. | 2020 | Details |
| A10560 | 31290748 | Turk J Gastroenterol | Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10561 | 31290733 | J Med Food | The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. | 2019 | Details |
| A10562 | 31290703 | J Med Food | Lycopene and Tomato Sauce Improve Hepatic and Cardiac Cell Biomarkers in Rats. | 2019 | Details |
| A10563 | 31290072 | Hepatol Int | Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2019 | Details |
| A10564 | 31289229 | Proc Natl Acad Sci U S A | YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity. | 2019 | Details |
| A10565 | 31288993 | Mol Metab | GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury. | 2019 | Details |
| A10567 | 31288346 | Zhonghua Yu Fang Yi Xue Za Zhi | [Childhood obesity and early target organ damage]. | 2019 | Details |
| A10568 | 31288283 | Z Gastroenterol | [Microbiome & NASH - partners in crime driving progression of fatty liver disease]. | 2019 | Details |
| A10569 | 31287572 | Hepatology | Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD. | 2019 | Details |
| A10570 | 31284753 | FASEB J | Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance. | 2019 | Details |
| A10571 | 31284538 | Molecules | The Modulatory Action of Vitamin D on the Renin-Angiotensin System and the Determination of Hepatic Insulin Resistance. | 2019 | Details |
| A10573 | 31284229 | Int Immunopharmacol | Activation of hepatic iNKT2 cells by α-GalCer ameliorates hepatic steatosis induced by high-fat diet in C57BL/6J mice. | 2019 | Details |
| A10574 | 31283861 | Oral Dis | Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways. | 2019 | Details |
| A10575 | 31283527 | Eur J Gastroenterol Hepatol | Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases. | 2020 | Details |
| A10576 | 31282996 | Biometrics | Estimation of covariance matrix of multivariate longitudinal data using modified Choleksky and hypersphere decompositions. | 2019 | Details |
| A10579 | 31282011 | J Gastroenterol Hepatol | Clinical Cases in Hepatitis: Towards improving liver disease management in Australia. | 2019 | Details |
| A10580 | 31281460 | Exp Ther Med | Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance. | 2019 | Details |
| A10581 | 31281067 | Dig Liver Dis | Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease. | 2019 | Details |
| A10582 | 31280650 | Organogenesis | Ectopic localization of autophagosome in fatty liver is a key factor for liver regeneration. | 2019 | Details |
| A10584 | 31280506 | Isr Med Assoc J | Non-alcoholic Fatty Liver Disease is Associated with Recurrent Urinary Tract Infection in Premenopausal Women Independent of Metabolic Syndrome. | 2019 | Details |
| A10585 | 31280255 | Aging (Albany NY) | Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study. | 2019 | Details |
| A10586 | 31280138 | Phytomedicine | Anti-hepatic steatosis activity of Sicyos angulatus extract in high-fat diet-fed mice and chemical profiling study using UHPLC-qTOF-MS/MS spectrometry. | 2019 | Details |
| A10587 | 31279904 | J Hepatol | Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease. | 2019 | Details |
| A10588 | 31279902 | J Hepatol | The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. | 2019 | Details |
| A10589 | 31279739 | Metabolism | Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. | 2019 | Details |
| A10590 | 31278890 | Med Sci Monit | A Novel Use of Model for End-Stage Liver Disease (MELD) Score in Guiding Therapeutic Antibiotics Choice for Critically Ill Cirrhotic Patients. | 2019 | Details |
| A10591 | 31278754 | J Physiol | Liver sympathetic denervation reverses obesity-induced hepatic steatosis. | 2019 | Details |
| A10592 | 31278418 | Eur J Nutr | Açaí (Euterpe oleracea Martius) supplementation in the diet during gestation and lactation attenuates liver steatosis in dams and protects offspring. | 2019 | Details |
| A10593 | 31278377 | Nat Rev Gastroenterol Hepatol | NAFLD in children: new genes, new diagnostic modalities and new drugs. | 2019 | Details |
| A10594 | 31278269 | Nat Commun | Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. | 2019 | Details |
| A10595 | 31277922 | Ultrasound Med Biol | Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis. | 2019 | Details |
| A10596 | 31277096 | Medicine (Baltimore) | The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: An observational Study. | 2019 | Details |
| A10597 | 31275587 | BMJ Open Gastroenterol | Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study. | 2019 | Details |
| A10598 | 31275584 | BMJ Open Gastroenterol | Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population. | 2019 | Details |
| A10599 | 31275421 | Evid Based Complement Alternat Med | The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats. | 2019 | Details |
| A10600 | 31275413 | Evid Based Complement Alternat Med | Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats. | 2019 | Details |
| A10601 | 31275407 | Evid Based Complement Alternat Med | Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review. | 2019 | Details |
| A10602 | 31275240 | Front Endocrinol (Lausanne) | Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency. | 2019 | Details |
| A10603 | 31274677 | J Am Assoc Nurse Pract | Readiness for the epidemic: The adult nonalcoholic fatty liver disease toolkit for primary care nurse practitioners. | 2020 | Details |
| A10604 | 31274482 | Asian J Androl | Histologically proven hepatic steatosis associates with lower testosterone levels in men with obesity. | 2021 | Details |
| A10605 | 31273855 | Phytother Res | Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis. | 2019 | Details |
| A10607 | 31273617 | Hepatol Int | Hepatology through the crystal ball. | 2019 | Details |
| A10608 | 31273595 | Dig Dis Sci | Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. | 2019 | Details |
| A10609 | 31272248 | Scand J Gastroenterol | Transient liver elastography in normal pregnancy - a longitudinal cohort study. | 2019 | Details |
| A10610 | 31272131 | J Gastroenterol Hepatol | Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution. | 2019 | Details |
| A10611 | 31272028 | J Nutr Biochem | 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis. | 2019 | Details |
| A10612 | 31271806 | Metabolism | Activation of G0/G1 switch gene 2 by endoplasmic reticulum stress enhances hepatic steatosis. | 2019 | Details |
| A10613 | 31271665 | Hepatology | Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. | 2019 | Details |
| A10614 | 31271251 | Mol Nutr Food Res | Diet Consisting of Balanced Yogurt, Fruit, and Vegetables Modifies the Gut Microbiota and Protects Mice against Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10615 | 31270645 | Mol Cell Biochem | Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells. | 2019 | Details |
| A10616 | 31270280 | Fukushima J Med Sci | Autoimmune hepatitis, fatty liver, and Fukushima. | 2019 | Details |
| A10617 | 31269941 | BMC Complement Altern Med | Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks. | 2019 | Details |
| A10619 | 31269758 | Mar Drugs | Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice. | 2019 | Details |
| A10620 | 31269076 | PLoS One | Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice. | 2019 | Details |
| A10621 | 31267355 | J Nat Med | Consumption of lycopene-rich tomatoes improved glucose homeostasis in rats via an increase in leptin levels. | 2019 | Details |
| A10623 | 31266893 | Proc Natl Acad Sci U S A | p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity. | 2019 | Details |
| A10624 | 31266632 | Biochem Biophys Res Commun | Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. | 2019 | Details |
| A10625 | 31266618 | Clin Liver Dis | The Effects of Hepatic Steatosis on the Natural History of HBV Infection. | 2019 | Details |
| A10626 | 31266306 | J Proteome Res | Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics. | 2019 | Details |
| A10627 | 31265967 | Nutrition | Creatine supplementation exacerbates ethanol-induced hepatic damage in mice. | 2019 | Details |
| A10628 | 31264313 | Phytother Res | Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial. | 2019 | Details |
| A10629 | 31263097 | Nat Commun | Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. | 2019 | Details |
| A10630 | 31263038 | J Immunol | Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages. | 2019 | Details |
| A10631 | 31262497 | Am J Cardiol | Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis). | 2019 | Details |
| A10632 | 31262487 | HPB (Oxford) | Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria. | 2019 | Details |
| A10633 | 31260793 | Contemp Clin Trials | REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis. | 2019 | Details |
| A10635 | 31260574 | J Eur Acad Dermatol Venereol | High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors. | 2019 | Details |
| A10636 | 31260143 | J Gastroenterol Hepatol | Genetic and lifestyle risk factors for advanced liver disease among men and women. | 2019 | Details |
| A10637 | 31260026 | JAMA Intern Med | Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2019 | Details |
| A10638 | 31258623 | Therap Adv Gastroenterol | Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention. | 2019 | Details |
| A10639 | 31258620 | Therap Adv Gastroenterol | The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. | 2019 | Details |
| A10640 | 31258138 | Turk J Gastroenterol | Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience. | 2019 | Details |
| A10641 | 31258135 | Turk J Gastroenterol | Non-alcoholic fatty liver disease: A growing public health problem in Turkey. | 2019 | Details |
| A10642 | 31257745 | Endocrinol Metab (Seoul) | Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults. | 2019 | Details |
| A10643 | 31256692 | J Diet Suppl | The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis. | 2019 | Details |
| A10644 | 31256424 | J Cell Physiol | microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes. | 2019 | Details |
| A10645 | 31256111 | J Xray Sci Technol | NAFLD evaluation: Which is more appropriate, multislice computed tomography or ultrasound real-time shear wave elastography? | 2019 | Details |
| A10646 | 31255807 | Clin Gastroenterol Hepatol | Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease. | 2019 | Details |
| A10647 | 31255652 | Gastroenterology | Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10648 | 31255630 | Dig Liver Dis | Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. | 2019 | Details |
| A10649 | 33305742 | Kathmandu Univ Med J (KUMJ) | Prevalence of Nonalcoholic Fatty Liver Disease in a Tertiary Care Teaching Hospital: A Cross Sectional Study in Province 4 of Nepal. | 2020 | Details |
| A10650 | 31254349 | FEBS Lett | Raman spectroscopic histology using machine learning for nonalcoholic fatty liver disease. | 2019 | Details |
| A10651 | 31254236 | Clin Rheumatol | Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. | 2019 | Details |
| A10652 | 31252332 | Micron | Application of a layered model for determination of the elasticity of biological systems. | 2019 | Details |
| A10653 | 31252266 | Biomed Pharmacother | Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. | 2019 | Details |
| A10654 | 31252193 | Clin Gastroenterol Hepatol | Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis. | 2019 | Details |
| A10656 | 31251928 | Gastroenterology | Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. | 2019 | Details |
| A10657 | 31251379 | JAMA Netw Open | Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis. | 2019 | Details |
| A10658 | 31251092 | Curr Med Res Opin | Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes. | 2019 | Details |
| A10659 | 31250564 | Physiol Rep | AdipoRon prevents myostatin-induced upregulation of fatty acid synthesis and downregulation of insulin activity in a mouse hepatocyte line. | 2019 | Details |
| A10660 | 31250467 | Aliment Pharmacol Ther | The PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng Study. | 2019 | Details |
| A10662 | 31246368 | Aliment Pharmacol Ther | Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. | 2019 | Details |
| A10663 | 31246081 | Eur J Paediatr Dent | The sweet danger of added sugars. | 2019 | Details |